Literature DB >> 26201795

Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension.

Moattar Raza Rizvi1,2, Mohammad Tauseef3, Mohd Shahid3, Rashmi Babbar4, Mohammad Fahim3, Puja Sakhuja5, Shiv Kumar Sarin6.   

Abstract

AIMS: To evaluate the participation of nitric oxide (NO) and prostaglandin (PGI2) on hyperdynamic state in endotoxemia-induced portal hypertension (EIP) induced by chronic endotoxemia.
METHODS: The portal pressure (PP) and mean arterial pressure (MAP) were recorded, in vivo before and after administration of L-NAME (NOS inhibitor) and indomethacin (specific blocker of COX). The vasoactive responses to acetylcholine of thoracic rat aortic rings were studied in vitro before and after nitric oxide and cyclooxygenase blockade using multichannel organ bath. The mRNA expression for isoforms of (cyclooxygenase) COX and nitric oxide synthase (NOS) were analyzed using RT-PCR.
RESULTS: Administration of both L-NAME and indomethacin in EIP rabbits significantly reduced (p < 0.05) the PP and reversed the MAP to normal as compared to sham-operated (SO) rabbits. There was impaired vasodilatory response to acetylcholine in EIP rabbits. L-NAME caused a significant reduction in acetylcholine-induced vasorelaxation in SO rabbits than EIP due to preexisting hyperemia in EIP. Indomethacin partially restored vasoresponsiveness to acetylcholine in EIP group. The mRNA expression of eNOS (endothelial NOS) and COX-1 (constitutive COX) were significantly higher in SO than EIP rabbits. iNOS (inducible NOS) and COX-2 (inducible COX) mRNA expression was seen only in EIP rabbits.
CONCLUSIONS: A significant component of acetylcholine-mediated vasorelaxation in EIP model is modulated by eNOS. There was increased production of contractile prostaglandin in EIP rabbits. iNOS and COX-2 play an important role in the hemodynamic abnormalities of PHT. This novel model of PHT produced by chronic splanchnic endotoxemia in rabbit, mimics impaired vasodilation and vasoreactivity akin to other models of PHT.

Entities:  

Keywords:  Cirrhosis; Nitric oxide; Non-cirrhotic portal hypertension; Prostaglandins; Vascular reactivity

Year:  2012        PMID: 26201795     DOI: 10.1007/s12072-012-9397-9

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  40 in total

Review 1.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

2.  Vascular reactivity in experimental portal hypertension.

Authors:  A Bomzon; L M Blendis
Journal:  Am J Physiol       Date:  1987-02

3.  LPS-induced imbalanced expression of hepatic vascular stress genes in cirrhosis: possible mechanism of increased susceptibility to endotoxemia.

Authors:  Rajiv Baveja; Steve Keller; Yukihiro Yokoyama; Natalie Sonin; Mark G Clemens; Jian X Zhang
Journal:  Shock       Date:  2002-04       Impact factor: 3.454

4.  The relationship between prostacyclin activity and pressure in the portal vein.

Authors:  G Hamilton; R C Phing; R A Hutton; P Dandona; K E Hobbs
Journal:  Hepatology       Date:  1982 Mar-Apr       Impact factor: 17.425

5.  Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats.

Authors:  J W Kiel; V Pitts; J N Benoit; D N Granger; A P Shepherd
Journal:  Am J Physiol       Date:  1985-02

6.  A rabbit model of non-cirrhotic portal hypertension by repeated injections of E.coli through indwelling cannulation of the gastrosplenic vein.

Authors:  Swati Omanwar; Moattar R Rizvi; Rachna Kathayat; Brij K Sharma; Giryesh K Pandey; Mohammad A Alam; Giryesh K Pandey; Veena Malhotra; Shiv K Sarin
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-08

7.  Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin.

Authors:  F E Xavier; R Aras-López; I Arroyo-Villa; L del Campo; M Salaices; L V Rossoni; M Ferrer; G Balfagón
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

8.  Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.

Authors:  J V Sitzmann; G B Bulkley; M C Mitchell; K Campbell
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

9.  Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

Authors:  T F Lüscher; P M Vanhoutte
Journal:  Hypertension       Date:  1986-04       Impact factor: 10.190

10.  Enhanced endothelium-dependent vasodilation in patients with cirrhosis.

Authors:  A Albillos; I Rossi; G Cacho; M V Martínez; I Millán; L Abreu; C Barrios; P Escartín
Journal:  Am J Physiol       Date:  1995-03
View more
  2 in total

Review 1.  The portal hypertension syndrome: etiology, classification, relevance, and animal models.

Authors:  Jaime Bosch; Yasuko Iwakiri
Journal:  Hepatol Int       Date:  2017-10-24       Impact factor: 6.047

Review 2.  Hyponatremia in Cirrhosis.

Authors:  Helbert Rondon-Berrios; Juan Carlos Q Velez
Journal:  Clin Liver Dis       Date:  2022-04-01       Impact factor: 6.265

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.